Pacira names senior VP, strategy
This article was originally published in Scrip
Parsippany, New Jersey-based Pacira Pharmaceuticals has named Dr Scott Braunstein to the newly created position of senior vice-president of strategy and corporate development. Dr Braunstein brings over 20 years of knowledge and experience from his time both as a practising physician and investor, as well as expertise from numerous commercial, consulting and operational roles advising on strategy and organizational objectives for biotechnology and pharmaceutical companies. He will be responsible for evaluating, integrating and optimizing the company's strategic opportunities for the lead commercial product Exparel (bupivacaine liposome injectable suspension); the company's hospital-based sales franchise; the DepoFoam-based internal pipeline product candidates; and external in-licensing and acquisition product candidates. Before joining Pacira, Dr Braunstein was at Everpoint Asset Management.